Altoona Center for Clinical Research
Research facility
Location:
Duncansville, PA,
United States (USA) (US)
ISNI: -
ROR: https://ror.org/022q8ez38
Show on Map:
Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety (2020)
Markman JD, Bolash RB, Mcalindon TE, Kivitz AJ, Pombo-Suarez M, Ohtori S, Roemer F, et al.
Journal article
Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 study (2020)
McInnes IB, Mease PJ, Kivitz AJ, Nash P, Rahman P, Rech J, Conaghan PG, et al.
Journal article
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: Long-Term (4-Year) Data from a Phase 3 Study (2018)
Mcinnes IB, Kivitz AJ, Nash P, Rahman P, Rech J, Kirkham B, Navarra SV, et al.
Conference contribution